Precision medicine in ovarian cancer: disparities and inequities in access to predictive biomarkers

Pathologica. 2024 Jun;116(3):141-143. doi: 10.32074/1591-951X-959.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Biomarkers, Tumor* / analysis
  • Female
  • Health Services Accessibility
  • Healthcare Disparities*
  • Humans
  • Ovarian Neoplasms* / diagnosis
  • Ovarian Neoplasms* / pathology
  • Precision Medicine*

Substances

  • Biomarkers, Tumor